what is micro dosing of glp-1 Found Health Launches Microdosing Program for Early Metabolic Dysfunction People Are Microdosing Weight-Loss Drugs

Baseline (Before Starting Ipamorelin) 12-lead ECG with QTc measurement Fasting IGF-1 level Fasting glucose and HbA1c (ipamorelin can raise fasting glucose transiently) Complete metabolic panel Document current SSRI, dose, and duration At 6-8 Weeks Repeat IGF-1 to confirm GH axis response Fasting glucose Symptom check: joint pain, water retention, paresthesias (GH-related), and any new or worsened anxiety, insomnia, or GI symptoms At 3 Months and Every 6 Months Thereafter Repeat ECG IGF-1 trending HbA1c if diabetic or prediabetic Reassess need for both agents The Endocrine Society's 2011 Clinical Practice Guideline on GH use in adults recommends IGF-1 monitoring every 6-12 months for patients on GH-axis therapy, with dose titration targeting IGF-1 in the age-adjusted upper-normal range [14]

This is perhaps the most important unknown in the entire field

Cell Renewal: Glutathione is involved in the production and repair of cellular components, contributing to overall energy production and cellular function

Superior Blood Sugar Control In head-to-head trials, tirzepatide reduced HbA1c by up to 2.6% compared to semaglutide's 1.9%

This is a critical study in the Ozempic lawsuit because the label does not warn of this side effect